These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 24746736)

  • 1. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
    Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
    J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
    Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
    Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adherence to guidelines for the treatment of venous thromboembolism in cancer patients: a retrospective analysis of 145 cases].
    Belhadj Chaidi R; Thollot C; Ferru A; Roblot P; Landron C
    J Mal Vasc; 2013 May; 38(3):185-92. PubMed ID: 23619202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and treatment of venous thromboembolism in patients with cancer].
    Struve S; Wendtner CM
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
    [No Abstract]   [Full Text] [Related]  

  • 5. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
    Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
    Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer and venous thromboembolism recurrence: The keys for an optimal management].
    Mahé I; Benhamou Y; Helfer H; Chidiac J
    Bull Cancer; 2018 May; 105(5):508-516. PubMed ID: 29544692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Venous thromboembolism and cancer].
    Meyer G
    Rev Pneumol Clin; 2014; 70(1-2):91-4. PubMed ID: 24566034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.
    Haas SK; Freund M; Heigener D; Heilmann L; Kemkes-Matthes B; von Tempelhoff GF; Melzer N; Kakkar AK;
    Clin Appl Thromb Hemost; 2012; 18(2):159-65. PubMed ID: 22275397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
    Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
    Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism prevention in patients undergoing colorectal surgery for cancer.
    Holwell A; McKenzie JL; Holmes M; Woods R; Nandurkar H; Tam CS; Bazargan A
    ANZ J Surg; 2014 Apr; 84(4):284-8. PubMed ID: 23782713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer and venous thromboembolism].
    Meyer G; Belmont L
    Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of recurrent venous thromboembolism in cancer patients.
    Romualdi E; Ageno W
    Thromb Res; 2016 Apr; 140 Suppl 1():S128-31. PubMed ID: 27067966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data.
    Jameson SS; Baker PN; Charman SC; Deehan DJ; Reed MR; Gregg PJ; Van der Meulen JH
    J Bone Joint Surg Br; 2012 Jul; 94(7):914-8. PubMed ID: 22733945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management?
    Howlett J; Benzenine E; Fagnoni P; Quantin C
    J Thromb Thrombolysis; 2020 Oct; 50(3):642-651. PubMed ID: 32020515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of venous thromboembolism in cancer patients according to guidelines after educative measures.
    Pillet A; Minne F; Belhadj Chaidi R; Chapelle G; Ferru A
    Bull Cancer; 2018 May; 105(5):486-492. PubMed ID: 29680153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019?].
    Debourdeau P; Cossou-Gbeto C; Takam-Sohwe T; Laroche JP
    Bull Cancer; 2020 Feb; 107(2):224-233. PubMed ID: 32005356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of venous thromboembolism in elective thoracic surgery.
    Gómez-Hernández MT; Rodríguez-Pérez M; Novoa-Valentín N; Jiménez-López M; Aranda-Alcaide JL; Varela-Simó G
    Arch Bronconeumol; 2013 Jul; 49(7):297-302. PubMed ID: 23542046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.